back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-07 14:19 Tx date 2024-09-06 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+80,244 vol |
840,580 | |
| Filed 2024-09-06 17:36 Tx date 2024-09-06 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
$6,439,099,536
+80,244 vol $80,244 each |
||
| Filed 2024-09-06 17:36 Tx date 2024-09-06 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
$6,439,099,536
+80,244 vol $80,244 each |
840,580 | |
| Filed 2024-09-06 17:34 Tx date 2024-09-06 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-80,244 vol |
40,000 | |
| Filed 2024-07-12 17:44 Tx date 2024-07-10 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
120,244 | |
| Filed 2023-09-29 16:21 Tx date 2023-09-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+20,245 vol |
760,336 | |
| Filed 2023-09-29 16:20 Tx date 2023-09-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-20,245 vol |
20,244 | |
| Filed 2023-03-31 16:44 Tx date 2023-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-446,000
-100,000 vol $4.46 each |
100,000 | |
| Filed 2022-12-02 20:14 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+80,991 vol |
740,091 | |
| Filed 2022-12-02 20:12 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-80,991 vol |
40,489 | |
| Filed 2022-10-05 18:08 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-195,600
-60,000 vol $3.26 each |
200,000 | |
| Filed 2022-10-05 18:06 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-221,400
-60,000 vol $3.69 each |
260,000 | |
| Filed 2022-10-05 18:05 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$171,286
+121,480 vol $1.41 each |
121,480 | |
| Filed 2022-10-05 18:03 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-03 13:20 Tx date 2021-09-28 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-50,000 vol |
659,100 | |
| Filed 2021-09-12 17:52 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
320,000 | ||
| Filed 2021-09-12 17:50 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Holder: Allendale KOP Investments, LP (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
11,000 | ||
| Filed 2021-09-12 17:49 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Holder: Willner Properties Services, Inc. (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
15,005 | ||
| Filed 2021-09-12 17:47 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
709,100 |